Whipplewood Advisors’s Haemonetics HAE Stock Holding History

Whipplewood Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14	Closed	-$1.09K	–	1222
2024 Q4	$1.09K	Buy	+14	New	+$1.13K	﹤0.01%	1006

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Whipplewood Advisors's HAE Position: Q1 2025 in Review

Whipplewood Advisors sold out of Haemonetics (HAE) in Q1 2025, closing a stake of 14 shares — an estimated $1.09K sold.

Whipplewood Advisors first reported a position in HAE in Q4 2024 and held it in 1 quarter. The position peaked at $1.09K in Q4 2024. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

Whipplewood Advisors reported no remaining Haemonetics position as of Q1 2025 after selling out during the quarter.
Whipplewood Advisors sold 14 Haemonetics shares in Q1 2025, an estimated $1.09K.
Whipplewood Advisors first reported a position in Haemonetics in Q4 2024 and held it in 1 quarter.
Whipplewood Advisors's Haemonetics position peaked at $1.09K in Q4 2024.
314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Whipplewood Advisors's 13F filing for Q1 2025, filed 10 Apr 2025.